Tradestie Institutional Equity Comparison Engine

PVLA vs ANNX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-17 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

PVLA Overall Edge

PVLA Captures Institutional Edge (3โ€“0 Pillars ยท 3โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Palvella Therapeutics, Inc. Common Stock (PVLA) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, PVLA trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus ANNX at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, PVLA sits in CONSOLIDATION (2nd %ile IV; Dealer Gamma Walls on Pro) against ANNX sits in BREAKDOWN (100th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
PVLA N/M vs ANNX N/M Fwd P/E
Growth & Margin Winner PVLA
Op Margin 0.0% vs 0.0% ยท YoY +0.0% vs +0.0%
Momentum & Technical Winner PVLA
1Y +72.4% vs +28.0% ยท 52W Pos 67% vs 18%
Options & Structure Winner PVLA
CONSOLIDATION (2nd %ile IV) vs BREAKDOWN (100th %ile IV)
PVLA NASDAQ
Palvella Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$144.35
-0.17% 1D
Market Cap $2.2B
1M Return +17.4%
1Y Return +72.42%
Forward P/E N/M
Unified AI Score
40.8 / 100 SELL
Tech 15.0 Fund 44.0 Flow 65.0 Mom 60.0
ANNX NASDAQ
Annexon, Inc. Common Stock
Pharmaceutical Preparations
$3.47
-2.8% 1D
Market Cap $747.8M
1M Return -13.47%
1Y Return +28.04%
Forward P/E N/M
Unified AI Score
43.5 / 100 HOLD
Tech 37.0 Fund 55.0 Flow 72.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: PVLA +72.42% ANNX +28.04% Spread: +44.38 pp (PVLA Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
PVLA TTM Op. Margin: 0.0% ANNX TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on PVLA vs ANNX. Trailing 12-month operating profitability (PVLA 0.0% vs ANNX 0.0%) and valuation multiples (PVLA N/M vs ANNX N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: PVLA (3) vs ANNX (2)
Institutional Metric PVLA ANNX Criterion Row Winner
Market Capitalization Scale $2.2B $747.8M Larger Scale PVLA
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +0.0% +0.0% Higher Growth Tie
Operating Margin (TTM) Profitability 0.0% 0.0% Higher Margin Tie
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -63.4% -130.8% Higher ROE PVLA
52-Week Range Position Momentum 67% ($72โ€“$180) 18% ($3โ€“$7) Stronger Trend PVLA
Beta / 30D Volatility Risk Regime 1.67ฮฒ ยท 75% Vol 1.70ฮฒ ยท 63% Vol Lower Realized Risk ANNX
Unified Institutional Score Composite Signal 40.8 / 100 (SELL) 43.5 / 100 (HOLD) Higher Composite ANNX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full PVLA vs ANNX Buy Guide
PVLA CONSOLIDATION
71d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 2nd %ile
IV Regime Compressed (<25th %ile)
Live PVLA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ANNX BREAKDOWN
88d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 100th %ile
IV Regime Extreme (>80th %ile)
Live ANNX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither PVLA nor ANNX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.